CHMP

July 5, 2016July 5, 2016

Lung Cancer Therapy Keytruda, Already OK’d for Different Cancers, Recommended for Approval in EU

Lung Cancer, News

Merck recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of the drug Keytruda (pembrolizumab), to be used ... Read more

December 7, 2015May 12, 2016

European Commission Grants Marketing Authorization for GSK’s Nucala (mepolizumab) For Adult Asthma

Asthma, News

GlaxoSmithKline (GSK) announced in a press release that Nucala® (mepolizumab) has been granted marketing authorization as an add-on treatment by the European Commission. After receiving Food and Drug Administration (FDA) approval ... Read more

October 26, 2015November 5, 2015

GSK’s Volibris (Ambrisetan) Indication Expanded for PAH in Europe After CHMP Positive Opinion

News, Pulmonary Hypertension

GSK, a world leading research-based pharmaceutical and health care company, recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has released a ... Read more

September 30, 2015November 6, 2015

GSK Announces Positive CHMP Opinion in Europe for Severe Refractory Eosinophilic Asthma Drug Mepolizumab

Asthma, News

GlaxoSmithKline, a leading research-based pharmaceutical and healthcare company, recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization ... Read more